Results 121 to 130 of about 484,803 (308)

Cutting edge strategies for diabetic wound care: Nanotechnology, bioengineering, and beyond

BMEMat, EarlyView.
Graphical abstract illustrates the challenges in diabetic wound healing, covering pathophysiology, formulation hurdles, and emerging therapeutic strategies. It highlights the role of hyperglycemia, formulation complexities, and advanced technologies like bioprinting and AI in improving diabetic wound management. Abstract Diabetic wounds affect millions
Usama Ahmad, Wan Nurhidayah Wan Hanaffi, Anas Islam, Aimen Salman, Mohd Muazzam Khan, Faiyaz Shakeel, Qiang Cai, Xiaojun Cai, Quazi T. H. Shubhra   +8 more
wiley   +1 more source

Autologous Bone Marrow‐Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study

Stem Cells Translational Medicine, 2013
Despite excellent short‐term results, long‐term survival of transplanted kidneys has not improved accordingly. Although alloimmune responses and calcineurin inhibitor‐related nephrotoxicity have been identified as main drivers of fibrosis, no effective ...
M. Reinders, J. D. de Fijter, H. Roelofs, I. Bajema, D. D. de Vries, A. Schaapherder, F. Claas, P. V. van Miert, D. Roelen, C. van Kooten, W. Fibbe, T. Rabelink   +11 more
semanticscholar   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

GATED SPECT IN PATIENTS WITH BIOPSY-NEGATIVE CARDIAC TRANSPLANT REJECTION

Вестник трансплантологии и искусственных органов, 2009
Humoral rejection of the cardiac allograft is still a challenging problem associated with high incidence of graft loss and patient mortality. These episodes of rejection are often more severe, and more difficult to treat, than classical acute cellular ...
E. N. Ostroumov, V. M. Zakharevich, E. D. Kotina, N. N. Mojeiko, A. G. Kupriyanova, E. I. Ryaboshtanova, B. N. Morozov, N. Z. Meboniya, S. V. Mironov, A. Y. Kormer, I. M. Ilynsky, L. V. Beletskaya, E. N. Kazakov   +12 more
doaj   +1 more source

Early tolerance in pediatric liver allograft recipients [PDF]

, 1994
The authors report on six pediatric liver transplant recipients for whom allograft tolerance occurred shortly after transplantation (ie, less than 1.5 years). All the patients had associated life-threatening viral complications.
Adrianna Zeevi, Andreas G. Tzakis, Bakr Nour, Calne, Hector Ramos, Hoffman, Jorge Reyes, Keenan, Lee, Murase, Nancy Reinsmoen, Powrie, Reinsmoen, Reyes, Rolides, Romagnani, Satoru Todo, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Takeuchi, Thomas E. Starzl, Tzakis   +25 more
core   +1 more source

The Banff 97 working classification of renal allograft pathology.

Kidney International, 1999
BACKGROUND Standardization of renal allograft biopsy interpretation is necessary to guide therapy and to establish an objective end point for clinical trials.
L. Racusen, K. Solez, R. Colvin, S. Bonsib, M. C. Castro, T. Cavallo, B. Croker, A. Demetris, C. Drachenberg, A. Fogo, P. Furness, L. Gaber, I. Gibson, Dennis Glotz, J. Goldberg, Joseph Grande, P. Halloran, H. E. Hansen, B. Hartley, P. Hayry, C. Hill, E. Hoffman, L. Hunsicker, A. Lindblad, N. Marcussen, M. Mihatsch, T. Nadasdy, P. Nickerson, T. Olsen, J. Papadimitriou, P. Randhawa, D. Rayner, I. Roberts, S. Rose, D. Rush, L. Salinas‐Madrigal, D. Salomon, S. Sund, E. Taskinen, K. Trpkov, Y. Yamaguchi   +40 more
semanticscholar   +1 more source

Macrophage‐targeted cerium‐tannic acid metal‐polyphenol framework nanoenzyme promotes in situ heart valves regeneration through adaptive immunomodulation

BMEMat, EarlyView.
A novel nanoenzyme based on cerium ions‐tannic acid metal‐polyphenol framework (FCT) has been developed and loaded onto DHVs for targeting M1 macrophages to reduce their ROS level and reprogram macrophage phenotype, thereby eliminating inflammation, promoting endothelialization and adaptive matrix remodeling of scaffolds, offering a promising strategy ...
Peng Song, Yunlong Wu, Xing Chen, Yafei Liu, Mengna Dong, Jiawei Shi, Xichi Wang, Nianguo Dong, Weihua Qiao, Qin Wang   +9 more
wiley   +1 more source

Use of OKT3 with ciclosporin and steroids for reversal of acute kidney and liver allograft rejection [PDF]

, 1987
OKT3 monoclonal antibody therapy was added to preexisting baseline immunosuppressive treatment with ciclosporin and steroids to treat rejection in 52 recipients of cadaveric livers and 10 recipients of cadaveric kidneys.
Demetris, AJ, Fung, JJ, Porter, KA
core   +1 more source

Antibody‐Mediated Rejection Criteria – an Addition to the Banff ′97 Classification of Renal Allograft Rejection

American Journal of Transplantation, 2003
Antibody‐mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellent outcomes even in patients highly sensitized to the ...
L. Racusen, R. Colvin, K. Solez, M. Mihatsch, P. Halloran, P. Campbell, M. Cecka, J. Cosyns, A. Demetris, M. Fishbein, A. Fogo, P. Furness, I. Gibson, D. Glotz, P. Hayry, Lawrence Hunsickern, M. Kashgarian, R. Kerman, A. Magil, R. Montgomery, K. Morozumi, V. Nickeleit, P. Randhawa, H. Regele, D. Serón, S. Seshan, S. Sund, K. Trpkov   +27 more
semanticscholar   +1 more source

Maximizing Neurovascular Outcomes of Facial Transplantation: A Comprehensive Review

Clinical Anatomy, EarlyView.
ABSTRACT Facial transplantation is a division of reconstructive surgery which aims to improve the function and appearance of a face that has endured severe disfigurement. Currently, the face transplant procedure uses allogenic tissue, harvested from a brain‐dead donor, to replace damaged facial components.
Olivia A. James, Faye Bennett
wiley   +1 more source